Interestingly, CDKN2A expression was correlated with worse prognosis of patients with other cancers, including Adrenocortical Carcinoma (ACC), Colon Adenocarcinoma (COAD), Liver Hepatocellular Carcinoma (LIHC), Uterine Corpus Endometrial Carcinoma (UCEC), and Uveal melanoma (UVM) (Fig. 5C). Here, CDKN2A is linked to colon adenocarcinoma.